Advertisement
Screener

SpyGlass Pharma, Inc. (SGP) Operating Expenses

2.8 / 5 stars · 68/120 Roast Me

SpyGlass Pharma, Inc. Operating Expenses

SpyGlass Pharma, Inc. (SGP) reported Operating Expenses of $21.97 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:OperatingExpenses · last filed 2026-08-06

  • SpyGlass Pharma, Inc. operating expenses for the quarter ending 2026-06-30 was $21.97M, a 136.28% increase year-over-year.
  • SpyGlass Pharma, Inc. operating expenses for the quarter ending 2026-03-31 was $15.41M, a 107.58% increase year-over-year.
  • SpyGlass Pharma, Inc. operating expenses for the quarter ending 2025-06-30 was $9.30M.
  • SpyGlass Pharma, Inc. operating expenses for the quarter ending 2025-03-31 was $7.42M.
  • SpyGlass Pharma, Inc. operating expenses for fiscal 2025 was $41.45M, a 53.15% increase from fiscal 2024.
  • SpyGlass Pharma, Inc. operating expenses for fiscal 2024 was $27.06M.
Period endOperating Expenses 3 monthOperating Expenses 6 monthOperating Expenses 12 month
2026-06-30$21.97M
10-Q · filed 2026-08-06
$37.38M
10-Q · filed 2026-08-06
2026-03-31$15.41M
10-Q · filed 2026-05-14
2025-12-31$41.45M
10-K · filed 2026-03-26
2025-06-30$9.30M
10-Q · filed 2026-08-06
$16.72M
10-Q · filed 2026-08-06
2025-03-31$7.42M
10-Q · filed 2026-05-14
2024-12-31$27.06M
10-K · filed 2026-03-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
Beta Bionics, Inc. (BBNX)United States$0.979B-9.66
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77
SI-BONE, Inc. (SIBN)United States$0.830B-49.82
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
IRADIMED CORP (IRMD)United States$1.089B52.92
ARTIVION, INC. (AORT)United States$1.123B-345.09
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92
ANGIODYNAMICS INC (ANGO)United States$0.632B-13.02
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
ORTHOPEDIATRICS CORP (KIDS)United States$0.592B